Practical guidelines for the recognition and diagnosis of dementia

Journal of the American Board of Family Medicine

Volumn 25, Issue 3, 2012, Pages 367-382

  Galvin, James E ^a   Sadowsky, Carl H ^b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c Premiere Research Institute   (United States)

Author keywords

Dementia; Diagnosis; Diagnostic techniques and procedures; Guidelines

Indexed keywords

ALZHEIMER DISEASE; BEHAVIOR; CAREGIVER; CLINICAL PRACTICE; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; GENERAL PRACTITIONER; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PSYCHOSIS; REVIEW;

ALGORITHMS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MASS SCREENING; PRIMARY HEALTH CARE; PSYCHOMETRICS; TIME FACTORS; UNITED STATES;

EID: 84861856038     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2012.03.100181     Document Type: Review

References (71)

1. deSouza L, Sarazin M, Goetz C, Dubois B. Clinical investigations in primary care. Front Neurol Neurosci 2009;24:1-11.
2. Dubois B, Picard G, Sarazin M. Early detection of Alzheimer's disease: new diagnostic criteria. Dialogues Clin Neurosci 2009;11:135-9.
3. Boustani M, Callahan CM, Unverzagt FW, et al. Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med 2005; 20:572-7. (Pubitemid 41026239)
4. Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003;138:927-37.
5. Alzheimer's Association. 2010 Alzheimer disease facts and figures. Alzheimer's & Dementia. Vol. 6. Available from: http://www.alz.org/ documents- custom/report-alzfactsfigures2010.pdf. Accessed 14 March 2012.
6. Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213-31. (Pubitemid 34508073)
7. National Institutes of Health and Clinical Excellence. Dementia: supporting people with dementia and their carers in health and social care. Available from: http://www.nice.org.uk/guidance/cg42. Accessed 27 March 2012.
8. van Hout HP, Vernooij-Dassen MJ, Stalman WA. Diagnosing dementia with confidence by GPs. Fam Pract 2007;24:616-21.
9. Langa KM, Chernew ME, Kabeto MU, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med 2001;16:770-8. (Pubitemid 34209065)
10. Salloway S, Correia S. Alzheimer disease: time to improve its diagnosis and treatment. Cleve Clin J Med 2009;76:49-58.
11. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405. (Pubitemid 32217456)
12. Cummings JL, Frank JC, Cherry D, et al. Guidelines for managing Alzheimer's disease: part II. Treatment. Am Fam Physician 2002;65:2525-34. (Pubitemid 34664744)
13. Cummings JL, Frank JC, Cherry D, et al. Guidelines for managing Alzheimer's disease: part I. Assessment. Am Fam Physician 2002;65:2263-72. (Pubitemid 34603057)
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44. (Pubitemid 14076461)
15. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-46. (Pubitemid 47058377)
16. Galasko D, Hansen LA, Katzman R, et al. Clinicalneuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994;51: 888-95. (Pubitemid 24286043)
17. Waldemar G, Dubois B, Emre M, et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007;14: e1-26.
18. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence- based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-53. (Pubitemid 32405708)
19. Hye A, Lynham S, Thambisetty M, et al. Proteomebased plasma biomarkers for Alzheimer's disease. Brain 2006;129:3042-50. (Pubitemid 44684524)
20. Iliffe S, Robinson L, Brayne C, et al. Primary care and dementia: 1. diagnosis, screening and disclosure. Int J Geriatr Psychiatry 2009;24:895-901.
21. Woods RT, Moniz-Cook E, Iliffe S, et al. Dementia: issues in early recognition and intervention in primary care. J R Soc Med 2003;96:320-4. (Pubitemid 36842992)
22. Cotter VT. Alzheimer's disease: issues and challenges in primary care. Nurs Clin North Am 2006; 41:83-93, vi. (Pubitemid 43259590)
23. Hinton L, Franz CE, Reddy G, Flores Y, Kravitz RL, Barker JC. Practice constraints, behavioral problems, and dementia care: primary care physicians' perspectives. J Gen Intern Med 2007;22:1487-92. (Pubitemid 47568681)
24. Reuben DB, Roth C, Kamberg C, Wenger NS. Restructuring primary care practices to manage geriatric syndromes: the ACOVE-2 intervention. J Am Geriatr Soc 2003;51:1787-93. (Pubitemid 37543367)
25. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 2005;331: 321-7.
26. Vestegaard M, Kerman K, Tamiya E. The study of Alzheimer's disease biomarkers: current role and future prospects of nanosensor technology. Nanobiotechnology 2006;2:5-16. (Pubitemid 47074469)
27. Milne A, Culverwell A, Guss R, Tuppen J, Whelton R. Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr 2008;20:911-26.
28. Winblad B, Wimo A. Assessing the societal impact of acetylcholinesterase inhibitor therapies. Alzheimer Dis Assoc Disord 1999;13(Suppl 2):S9-19.
29. Wimo A. Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations. Drugs Aging 2004;21:279-95. (Pubitemid 38530455)
30. Mesterton J, Wimo A, By A, Langworth S, Winblad B, Jonsson L. Cross-sectional observational study on the societal costs of Alzheimer's disease. Curr Alzheimer Res 2010;7:358-67.
31. Wilkinson D, Sganga A, Stave C, O'Connell B. Implications of the Facing Dementia Survey for health care professionals across Europe. Int J Clin Pract Suppl 2005;27-31. (Pubitemid 40333122)
32. Weaver J, Espinoza R, Weintraub N. The utility of PET brain imaging in the initial evaluation of dementia. J Am Med Dir Assoc 2007;8:150-7. (Pubitemid 46344868)
33. Christensen DD, Lin P. Practical treatment strategies for patients with Alzheimer's disease. J Fam Pract 2007;56:S17-23. (Pubitemid 350309036)
34. Bamford C, Eccles M, Steen N, Robinson L. Can primary care record review facilitate earlier diagnosis of dementia? Fam Pract 2007;24:108-16. (Pubitemid 47079259)
35. Ramakers IH, Visser PJ, Aalten P, et al. Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dement Geriatr Cogn Disord 2007;24:300-6. (Pubitemid 47482078)
36. Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol 2006;63:1312-7.
37. Buchman AS, Schneider JA, Leurgans S, Bennett DA. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology 2008; 71:499-504.
38. Galvin JE, Powlishta KK, Wilkins K, et al. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch Neurol 2005;62:758-65. (Pubitemid 40656091)
39. Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. J Am Geriatr Soc 2005;53:871-4. (Pubitemid 41656936)
40. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000;15:1021-7.
41. Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry 2006;21:349-55.
42. Borson S, Scanlan JM, Chen P, Ganguli M. The Mini- Cog as a screen for dementia: validation in a populationbased sample. J Am Geriatr Soc 2003;51:1451-4. (Pubitemid 37259876)
43. Ismail Z, Rajji TK, Shulman KI. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 2010;25:111-20.
44. Galvin JE, Roe CM, Coats MA, Morris JC. Patient's rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia. Arch Neurol 2007;64:725-30. (Pubitemid 46795172)
45. Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC. Relationship of dementia screening tests with biomarkers of Alzheimer's disease. Brain 2010; 133:3290-300.
46. Borson S, Scanlan J, Hummel J, Gibbs K, Lessig M, Zuhr E. Implementing routine cognitive screening of older adults in primary care: process and impact on physician behavior. J Gen Intern Med 2007;22:811-7. (Pubitemid 46763987)
47. Holmes SB, Adler D. Dementia care: critical interactions among primary care physicians, patients and caregivers. Prim Care 2005;32:671-82, vi. (Pubitemid 41242367)
48. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-86.
49. Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 1992;40:1129-34.
50. Fitz AG, Teri L. Depression, cognition, and functional ability in patients with Alzheimer's disease. J Am Geriatr Soc 1994;42:186-91. (Pubitemid 24057358)
51. Monllau A, Pena-Casanova J, Blesa R, et al. [Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project]. Neurologia 2007;22: 493-501.
52. Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord 2007;24:375-9. (Pubitemid 350036694)
53. Juva K, Makela M, Erkinjuntti T, et al. Functional assessment scales in detecting dementia. Age Ageing 1997;26:393-400. (Pubitemid 27448384)
54. Craig D, Mirakhur A, Hart DJ, McIlroy SP, Passmore AP. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Am J Geriatr Psychiatry 2005;13:460-8.
55. Steffens DC, Maytan M, Helms MJ, Plassman BL. Prevalence and clinical correlates of neuropsychiatric symptoms in dementia. Am J Alzheimers Dis Other Demen 2005;20:367-73. (Pubitemid 43030926)
56. Lyketsos CG, Lee HB. Diagnosis and treatment of depression in Alzheimer's disease. A practical update for the clinician. Dement Geriatr Cogn Disord 2004; 17:55-64. (Pubitemid 37499969)
57. Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000;12:233-9. (Pubitemid 30303778)
58. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987;48(Suppl):9-15. (Pubitemid 17091427)
59. Family Caregiver Alliance. Caregiver assessment: principles, guidelines and strategies for change. Report from a National Consensus Development Conference. Vol. 1. San Francisco: Family Caregiver Alliance; 2006.
60. Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns 2000;40:173-85. (Pubitemid 30195758)
61. Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1154-66. (Pubitemid 32405709)
62. Lyketsos CG, Colenda CC, Beck C, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006;14:561-72. (Pubitemid 44036480)
63. Galvin JE, Roe CM, Powlishta KK, et al. The AD8: a brief informant interview to detect dementia. Neurology 2005;65:559-64. (Pubitemid 41170715)
64. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-9. (Pubitemid 12117513)
65. Luchsinger JA, Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 2004;6:261-6. (Pubitemid 39359464)
66. Dunn N, Mullee M, Perry VH, Holmes C. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord 2005;19:91-4. (Pubitemid 41073086)
67. Scanlan JM, Binkin N, Michieletto F, Lessig M, Zuhr E, Borson S. Cognitive impairment, chronic disease burden, and functional disability: a population study of older Italians. Am J Geriatr Psychiatry 2007;15:716-24.
68. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9. (Pubitemid 41623495)
69. Folsom DP, Gilmer T, Barrio C, et al. A longitudinal study of the use of mental health services by persons with serious mental illness: do Spanishspeaking Latinos differ from English-speaking Latinos and Caucasians? Am J Psychiatry 2007;164: 1173-80. (Pubitemid 47292405)
70. Teng EL, Manly JJ. Neuropsychological testing: helpful or harmful? Alzheimer Dis Assoc Disord 2005;19:267-71. (Pubitemid 44366631)
71. Luis CA, Keegan AP, Mullan M. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry 2009;24:197-201.